Mar. 2, 2012—New details on the DNA-cutting activity of topoisomerase II, a target of anti-cancer drugs, could lead to better chemotherapeutic agents.
Feb. 23, 2012—Vanderbilt researchers have discovered a new molecular participant in the Wnt signaling pathway, which plays important roles in cell growth, development and cancer.
Feb. 15, 2012—New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly.
Jan. 13, 2012—Wearing a nicotine patch may help improve memory loss in older adults with mild cognitive impairment, according to a study published this week by Paul Newhouse, director of the Center for Cognitive Medicine.
Jan. 5, 2012—About half of kidney patients will die from heart disease within five years of starting dialysis, yet patients with kidney failure are rarely included in heart disease research. Jorge Gamboa, M.D., T. Alp Ikizler, M.D., and Nancy Brown, M.D., completed a small study that suggests a more personalized approach to selecting medication for heart disease...
Dec. 15, 2011—Protein helps ensure proper division of chromosomes during cell division.
Dec. 15, 2011—Host cell protein may be a target for strategies to limit spread of virus-induced squamous cell cancers.
Dec. 1, 2011—Structural biology studies of a bacterial protein suggest a new target for treating life-threatening heart infection.
Nov. 4, 2011—Light and the hormone melatonin may play important roles in the developing brain.
Oct. 7, 2011—A protein critical in heart development may also play a part in colon cancer progression.
Sep. 29, 2011—Vanderbilt University investigators have discovered surprising new insights into the actions of NSAIDs.
Aug. 26, 2011—The antibiotics of the future could take a page from the immune system’s playbook – and “starve” bacteria of the nutrients they need.